ADDEX THERAPEUTICS LTD

Analyst Reco. Addex Therapeutics Ltd Nasdaq

Equities

ADXN

US00654J2069

Market Closed - Nasdaq Other stock markets 07:15:19 25/06/2024 pm IST			5-day change	1st Jan Change
7.98 ^USD	+3.64%		-2.09%	+31.90%

06/06	Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024
06/06	Addex Therapeutics' Q1 Net Loss Widens; Revenue Down	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Addex to Present at BioEURquity Europe 2024	08/05	DJ
HC Wainwright Downgrades Addex Therapeutics to Neutral From Buy	23/22/23	MT
Addex Terminates Dipraglurant Phase 2b/3 Study in Patients with Dyskinesia Associated with Parkinson's Disease due to Slow Recruitment Rate	17/22/17	CI
HC Wainwright Adjusts Addex Therapeutics' Price Target to $15 From $21, Keeps Buy Rating	31/22/31	MT
HC Wainwright Adjusts Addex Therapeutics' Price Target to $21 from $28, Maintains Buy Rating	11/22/11	MT
ADDEX THERAPEUTICS : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target	21/21/21	MT
Addex Therapeutics : Van Leeuwenhoeck Issues Equity Research Note Highlighting Value of Recent Indivior Strategic Partnership on GABAB PAM	02/18/02	GL
Addex Therapeutics : Van Leeuwenhoeck Issues Research Note on Addex Therapeutics	08/16/08	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer